Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis
- PMID: 19628375
- PMCID: PMC2825750
- DOI: 10.1016/j.schres.2009.03.035
Symptoms as mediators of the relationship between neurocognition and functional outcome in schizophrenia: a meta-analysis
Abstract
Background: Neurocognitive functioning in schizophrenia has received considerable attention because of its robust prediction of functional outcome. Psychiatric symptoms, in particular negative symptoms, have also been shown to predict functional outcome, but have garnered much less attention. The high degree of intercorrelation among all of these variables leaves unclear whether neurocognition has a direct effect on functional outcome or whether that relationship to functional outcome is partially mediated by symptoms.
Methods: A meta-analysis of 73 published English language studies (total n=6519) was conducted to determine the magnitude of the relationship between neurocognition and symptoms, and between symptoms and functional outcome. A model was tested in which symptoms mediate the relationship between neurocognition and functional outcome. Functional outcome involved measures of social relationships, school and work functioning, and laboratory assessments of social skill.
Results: Although negative symptoms were found to be significantly related to neurocognitive functioning (p<.01) positive symptoms were not (p=.97). The relationship was moderate for negative symptoms (r=-.24, n=4757, 53 studies), but positive symptoms were not at all related to neurocogniton (r=.00, n=1297, 25 studies). Negative symptoms were significantly correlated with functional outcome (r=-.42, p<.01), and again the correlation was higher than for positive symptoms (r=-.03, p=.55). Furthermore, our findings support a model in which negative symptoms significantly mediate the relationship between neurocognition and functional outcome (Sobel test p<.01).
Conclusions: Although neurocognition and negative symptoms are both predictors of functional outcome, negative symptoms might at least partially mediate the relationship between neurocognition and outcome.
Conflict of interest statement
None of the authors has a financial conflict of interest.
Similar articles
-
Neurocognition, insight into illness and subjective quality-of-life in schizophrenia: what is their relationship?Schizophr Res. 2011 Apr;127(1-3):157-62. doi: 10.1016/j.schres.2010.12.004. Epub 2011 Jan 6. Schizophr Res. 2011. PMID: 21211943 Free PMC article.
-
Neurocognition and symptoms identify links between facial recognition and emotion processing in schizophrenia: meta-analytic findings.Schizophr Res. 2013 Dec;151(1-3):78-84. doi: 10.1016/j.schres.2013.10.015. Epub 2013 Nov 21. Schizophr Res. 2013. PMID: 24268469 Free PMC article. Review.
-
Clinical symptoms, mainly negative symptoms, mediate the influence of neurocognition and social cognition on functional outcome of schizophrenia.Schizophr Res. 2013 May;146(1-3):231-7. doi: 10.1016/j.schres.2013.02.009. Epub 2013 Mar 9. Schizophr Res. 2013. PMID: 23478155
-
Disorganization and reality distortion in schizophrenia: a meta-analysis of the relationship between positive symptoms and neurocognitive deficits.Schizophr Res. 2010 Aug;121(1-3):1-14. doi: 10.1016/j.schres.2010.05.033. Epub 2010 Jun 25. Schizophr Res. 2010. PMID: 20579855 Free PMC article.
-
The relationship between negative symptoms and MATRICS neurocognitive domains: A meta-analysis and systematic review.Prog Neuropsychopharmacol Biol Psychiatry. 2023 Dec 20;127:110833. doi: 10.1016/j.pnpbp.2023.110833. Epub 2023 Jul 22. Prog Neuropsychopharmacol Biol Psychiatry. 2023. PMID: 37482283
Cited by
-
Psychosis risk individuals show poor fitness and discrepancies with objective and subjective measures.Sci Rep. 2021 May 10;11(1):9851. doi: 10.1038/s41598-021-89301-5. Sci Rep. 2021. PMID: 33972634 Free PMC article.
-
Timing of antipsychotics and benzodiazepine initiation during a first episode of psychosis impacts clinical outcomes: Electronic health record cohort study.Front Psychiatry. 2022 Sep 23;13:976035. doi: 10.3389/fpsyt.2022.976035. eCollection 2022. Front Psychiatry. 2022. PMID: 36213895 Free PMC article.
-
Improving Facial Emotion Recognition in Schizophrenia: a Controlled Study Comparing Specific and Attentional Focused Cognitive Remediation.Front Psychiatry. 2016 Jun 21;7:105. doi: 10.3389/fpsyt.2016.00105. eCollection 2016. Front Psychiatry. 2016. PMID: 27445866 Free PMC article.
-
20-year neurocognitive development following a schizophrenia spectrum disorder and associations with symptom severity and functional outcomes.Psychol Med. 2024 Jul;54(9):2004-2014. doi: 10.1017/S0033291724000096. Epub 2024 Feb 12. Psychol Med. 2024. PMID: 38343378 Free PMC article.
-
Predicting Real-World Functioning in Schizophrenia: The Relative Contributions of Neurocognition, Functional Capacity, and Negative Symptoms.Front Psychiatry. 2021 Mar 19;12:639536. doi: 10.3389/fpsyt.2021.639536. eCollection 2021. Front Psychiatry. 2021. PMID: 33815171 Free PMC article.
References
-
- Addington J, Addington D. Facial affect recognition and information processing in schizophrenia and bipolar disorder. Schizophrenia Research. 1998a;32(3):171–181. - PubMed
-
- Addington J, Addington D. Visual attention and symptoms in schizophrenia: a 1-year follow-up. Schizophrenia Research. 1998b;34(1–2):95–99. - PubMed
-
- Addington J, Addington D. Neurocognitive and social functioning in schizophrenia. Schizophrenia Bulletin. 1999;25(1):173–182. - PubMed
-
- Addington J, Addington D. Neurocognitive and social functioning in schizophrenia: a 2.5 year follow-up study. Schizophrenia Research. 2000;44:47–56. - PubMed
-
- Addington J, Addington D, Maticka-Tyndale E. Cognitive functioning and positive and negative symptoms in schizophrenia. Schizophr Res. 1991;5(2):123–134. - PubMed
Publication types
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical